Company News

  • 14 August 2019

    Ancora Heart begins enrolment in AccuCinch device trial

    Cardiac therapies developer Ancora Heart has started patient enrolment in the CorCinch EU clinical trial of AccuCinch Ventricular Repair System to treat reduced ejection fraction systolic heart failure (HFrEF).

Close
Close
Close

Go Top